Merck & Co Inc

NYSE:MRKUnited States

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products include therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3, an inhibitory canonical Notch ligand. Its lead candidate, Restoret, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wingless-related integration site signaling pathway.

Contact Information

Headquarters

2000 Galloping Hill RoadKENILWORTH, NJ, United States 07033

Phone

908-740-4000

Fax

908-423-1987

Executives

Chairman of the Board, President, Chief Executive Officer

Robert Davis

Chief Financial Officer, Executive Vice President

Caroline Litchfield

Chief Human Resource Officer

Betty Larson

Executive Vice President, Chief Information and Digital Officer

David Williams

Executive Vice President, General Counsel, Corporate Secretary

Jennifer Zachary